What is CG Oncology's net income?

CG Oncology (CGON) reported net income of -$60.2M in Q1 2026.

How has CG Oncology's net income changed year-over-year?

CG Oncology's net income decreased by 74.7% year-over-year, from -$34.45M to -$60.2M.

What is the long-term trend for CG Oncology's net income?

Over 2 years (2023 to 2025), CG Oncology's net income has grown at a 82.0% compound annual growth rate (CAGR), from -$48.61M to -$161M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

CG Oncology CGON Net Income

Net Income at other companies

PfizerPFE

$2.69B-9.4%

Johnson & JohnsonJNJ

$5.24B-52.4%

Gilead SciencesGILD

$2.02B+53.7%

ImmunityBio, Inc.IBRX

-$632.78M-388%

Cogent Biosciences, Inc.COGT

——

Immunovant, Inc.IMVT

——

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's net income?: CG Oncology (CGON) reported net income of -$60.2M in Q1 2026.
How has CG Oncology's net income changed year-over-year?: CG Oncology's net income decreased by 74.7% year-over-year, from -$34.45M to -$60.2M.
What is the long-term trend for CG Oncology's net income?: Over 2 years (2023 to 2025), CG Oncology's net income has grown at a 82.0% compound annual growth rate (CAGR), from -$48.61M to -$161M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.